Lenvatinib Mesylate Intermediate CAS 205448-65-3 Ubunyulu > 98.0% (HPLC) Factory

Inkcazelo emfutshane:

Igama leMichiza: Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate

CAS: 205448-65-3

Ubunyulu: >98.0% (HPLC)

Imbonakalo: Okumhlophe-Kumhlophe ukuya kwiPowder etyheli

Umbindi weLenvatinib Mesylate CAS 857890-39-2

E-Mail: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Iipropati zeMichiza:

Igama leMchiza I-Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate
Izithethantonye I-1,4-Dihydro-7-Methoxy-4-Oxo-6-Quinolinecarboxylic Acid Methyl Ester;7-Methoxy-4-Oxo-1,4-Dihydro-Quinoline-6-Carboxylic Acid Methyl Ester;ILenvatinib ePhakathi 3
Inombolo yeCAS 205448-65-3
Inombolo yeCAT RF-PI1973
Ubume beStokhwe Kwi-Stock, iMveliso yeMveliso ye-50 MT / Year
Ifomula yeemolekyuli C12H11NO4
Ubunzima beMolekyuli 233.22
Indawo yokubilisa 421.0±45.0℃
Ukuxinana 1.267±0.060 g/cm3
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo I-Off-White ukuya kwiPowder etyheli
Ubunyulu / Indlela yokuHlalutya >98.0% (HPLC)
Ilahleko ekomisweni <1.00%
Intsalela kwi-Ignition <0.50%
Ukungcola ngokupheleleyo <2.00%
H-NMR Iyahambelana noLwakhiwo
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa AbaPhakathi bamayeza

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

1

FAQ:

Isicelo:

I-Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate (CAS: 205448-65-3) iphakathi kweLenvatinib Mesylate (CAS: 857890-39-2).I-Lenvatinib, ethengiswa phantsi kwegama le-brand Lenvima phakathi kwabanye, liyeza elichasayo lomhlaza kunyango lweentlobo ezithile zomhlaza wegilo kunye neminye imihlaza ngokunjalo.Yaphuhliswa ngu-Eisai Co. kwaye isebenza njenge-multiple kinase inhibitor ngokuchasene ne-VEGFR1, VEGFR2 kunye ne-VEGFR3 kinases.I-Lenvatinib ivunyiwe (ukususela kwi-2015) yonyango lomhlaza we-thyroid owahlukileyo onokuthi ubuyele kwindawo okanye i-metastatic, i-progressive, kwaye ayizange iphendule unyango nge-iodine ye-radioactive (i-radioiodine).NgoMeyi ka-2016, i-US Food and Drug Administration (i-FDA) yavuma (ngokudityaniswa ne-everolimus) kunyango lwe-renal cell carcinoma ehamba phambili elandela unyango olunye lwangaphambili oluchasene ne-angiogenic.Iyeza likwavunyiwe e-US nakwiManyano yaseYurophu ye-hepatocellular carcinoma engenakususwa ngotyando kwizigulana ezingakhange zifumane unyango lomhlaza ngomlomo okanye ngenaliti.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi